Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CRON Cronos Group	$2.59 +1.2%	$2.16	$1.60 ▼ $2.77	$992.46M	1.01	1.87 million shs	5.21 million shs
CUS Chemtrade Electrochem Inc,		C$0.00	C$1.18 ▼ C$1.65	C$306.50M	N/A	271,090 shs	13,269 shs
SLS SELLAS Life Sciences Group	$1.92 -0.3%	$1.81	$0.77 ▼ $2.27	$201.65M	2.26	2.54 million shs	1.56 million shs
TLRY Tilray Brands	$1.47 +6.9%	$0.72	$0.35 ▼ $1.88	$1.61B	1.85	42.57 million shs	78.86 million shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CRON Cronos Group	+0.39%	+5.79%	+24.27%	+24.88%	+16.36%
CUS Chemtrade Electrochem Inc,	0.00%	0.00%	0.00%	0.00%	0.00%
SLS SELLAS Life Sciences Group	+5.49%	+3.78%	+7.87%	+12.28%	+42.22%
TLRY Tilray Brands	-5.52%	+29.25%	+95.80%	+194.88%	-21.71%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CRON Cronos Group	0.7908 of 5 stars	0.0	3.0	0.0	0.0	2.5	0.0	1.3
CUS Chemtrade Electrochem Inc,	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SLS SELLAS Life Sciences Group	2.9046 of 5 stars	3.5	2.0	0.0	0.0	4.1	1.7	0.6
TLRY Tilray Brands	2.2222 of 5 stars	3.2	1.0	0.0	0.0	2.6	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CRON Cronos Group	0.00	N/A	N/A	N/A
CUS Chemtrade Electrochem Inc,	0.00	N/A	N/A	N/A
SLS SELLAS Life Sciences Group	3.00	Buy	$7.00	265.54% Upside
TLRY Tilray Brands	2.33	Hold	$1.94	32.25% Upside

Current Analyst Ratings Breakdown

Latest CUS, TLRY, CRON, and SLS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/25/2025	TLRY Tilray Brands	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$1.50 ➝ $2.00
7/29/2025	TLRY Tilray Brands	Zelman & Associates Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral
7/16/2025	SLS SELLAS Life Sciences Group	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$4.00 ➝ $7.00

(Data available from 8/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CRON Cronos Group	$117.61M	8.44	$0.00 per share	5,480.10	$2.95 per share	0.88
CUS Chemtrade Electrochem Inc,	N/A	N/A	N/A	N/A	N/A	N/A
SLS SELLAS Life Sciences Group	$1M	201.65	N/A	N/A	$0.25 per share	7.66
TLRY Tilray Brands	$210.48M	7.66	$0.15 per share	10.03	$1.40 per share	1.05

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CRON Cronos Group	$41.08M	$0.05	51.82	86.37	N/A	14.19%	-3.78%	-3.62%	11/11/2025 (Estimated)
CUS Chemtrade Electrochem Inc,	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
SLS SELLAS Life Sciences Group	-$30.88M	-$0.32	N/A	N/A	N/A	N/A	-132.51%	-92.79%	11/12/2025 (Estimated)
TLRY Tilray Brands	-$2.19B	-$2.31	N/A	N/A	N/A	-265.69%	-6.83%	-5.45%	10/9/2025 (Estimated)

Latest CUS, TLRY, CRON, and SLS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q2 2025	SLS SELLAS Life Sciences Group	-$0.0767	-$0.07	+$0.0067	-$0.07	N/A	N/A
8/7/2025	Q2 2025	CRON Cronos Group	-$0.02	-$0.10	-$0.08	-$0.10	$45.73 million	$33.46 million
7/28/2025	Q4 2025	TLRY Tilray Brands	-$0.03	$0.02	+$0.05	-$1.30	$250.41 million	$224.54 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CRON Cronos Group	N/A	N/A	N/A	N/A	N/A
CUS Chemtrade Electrochem Inc,	C$0.02	2.44%	N/A	N/A	N/A
SLS SELLAS Life Sciences Group	N/A	N/A	N/A	N/A	N/A
TLRY Tilray Brands	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CRON Cronos Group	N/A	24.65	23.53
CUS Chemtrade Electrochem Inc,	N/A	N/A	N/A
SLS SELLAS Life Sciences Group	N/A	4.91	4.91
TLRY Tilray Brands	0.20	2.46	1.49

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CRON Cronos Group	8.71%
CUS Chemtrade Electrochem Inc,	N/A
SLS SELLAS Life Sciences Group	17.38%
TLRY Tilray Brands	9.35%

Insider Ownership

Company	Insider Ownership
CRON Cronos Group	7.30%
CUS Chemtrade Electrochem Inc,	N/A
SLS SELLAS Life Sciences Group	1.40%
TLRY Tilray Brands	0.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CRON Cronos Group	450	383.04 million	355.08 million	Optionable
CUS Chemtrade Electrochem Inc,	60	186.89 million	N/A	Not Optionable
SLS SELLAS Life Sciences Group	10	105.30 million	103.82 million	Not Optionable
TLRY Tilray Brands	2,842	1.10 billion	1.09 billion	Optionable

CUS, TLRY, CRON, and SLS Headlines

Recent News About These Companies

Tilray Brands (NASDAQ:TLRY) Shares Down 5.9% - Should You Sell?

3 hours ago | marketbeat.com

Jefferies Raises Tilray (TLRY) Price Target on Potential Cannabis Rescheduling

August 28 at 8:10 AM | insidermonkey.com

Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains

August 28 at 7:00 AM | globenewswire.com

Tilray Brands, Inc.: Tilray Brands Successfully Regains Compliance with Nasdaq's Minimum Bid Price Requirement

August 28 at 5:33 AM | finanznachrichten.de

Why Tilray (TLRY) Shares Are Plunging Today

August 28 at 5:33 AM | msn.com

Tilray Brands (NASDAQ:TLRY) Sees Unusually-High Trading Volume Following Analyst Upgrade

August 28 at 2:58 AM | americanbankingnews.com

Tilray Brands, Inc. (TLRY) Stock Falls Amid Market Uptick: What Investors Need to Know

August 27 at 7:00 PM | zacks.com

Tilray Brands Successfully Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

August 27 at 5:11 PM | financialpost.comF

Tilray Brands, Inc. Announces Compliance with Nasdaq Minimum Bid Price Requirement

August 27 at 5:11 PM | quiverquant.comQ

Tilray Brands Successfully Regains Compliance with Nasdaq's Minimum Bid Price Requirement

August 27 at 5:02 PM | globenewswire.com

Tilray Brands (NASDAQ:TLRY) Shares Up 3.2% on Analyst Upgrade

August 27 at 11:18 AM | marketbeat.com

Tilray Brands (NASDAQ:TLRY) Sees Strong Trading Volume After Analyst Upgrade

August 27 at 10:15 AM | marketbeat.com

Tilray Brands (NASDAQ:TLRY) Trading 3.2% Higher After Analyst Upgrade

August 27 at 2:29 AM | americanbankingnews.com

Tilray Brands (NASDAQ:TLRY) Shares Gap Up on Analyst Upgrade

August 27 at 2:50 AM | americanbankingnews.com

Tilray: Sell The U.S. Rescheduling Rally

August 26 at 5:14 PM | seekingalpha.com

Why Tilray (TLRY) Stock Is Up Today

August 26 at 5:05 PM | msn.com

US cannabis stocks rally as Trump backs rescheduling

August 26 at 4:04 PM | proactiveinvestors.com

Tilray Brands (TLRY) Jumps 23% as Analyst Goes Bullish on Cannabis Prospects

August 26 at 1:32 PM | insidermonkey.com

Here's why Tilray stock price is soaring and why it may crash soon

August 26 at 1:05 PM | invezz.comI

Tilray Brands (NASDAQ:TLRY) Trading Up 18.7% on Analyst Upgrade

August 26 at 11:13 AM | marketbeat.com

Tilray Brands shares gain as analysts boost price target on cannabis rescheduling optimism

August 26 at 11:13 AM | proactiveinvestors.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

CUS, TLRY, CRON, and SLS Company Descriptions

Cronos Group NASDAQ:CRON

$2.59 +0.03 (+1.21%)

Closing price 03:59 PM Eastern

Extended Trading

$2.58 -0.01 (-0.23%)

As of 04:06 PM Eastern

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Chemtrade Electrochem Inc, TSE:CUS

Chemtrade Electrochem Inc, formerly Canexus Corp is a Canada-based company engaged in operating North American sodium chlorate production facilities; a North American chlor-alkali production facility and a sodium chlorate and chlor-alkali production facility. Its segments are North America Sodium Chlorate, North America Chlor-alkali (NACA) and South America (sodium chlorate and chlor-alkali). The North America Sodium Chlorate segment sells sodium chlorate to the South America segment and provides transloading services to the NACA segment for caustic soda transloaded from barges into trucks for delivery to NACA customers. It produces sodium chlorate in Beauharnois, Quebec; Brandon, Manitoba, and Nanaimo, British Columbia; chlor-alkali products (caustic soda, chlorine, and hydrochloric acid) in North Vancouver, British Columbia, and sodium chlorate and chlor-alkali products in Espirito Santo, Brazil. It caters its production to the pulp and paper, water treatment and oil and gas sectors.

SELLAS Life Sciences Group NASDAQ:SLS

$1.92 -0.01 (-0.26%)

Closing price 03:59 PM Eastern

Extended Trading

$1.92 +0.00 (+0.26%)

As of 04:05 PM Eastern

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.

Tilray Brands NASDAQ:TLRY

$1.46 +0.10 (+6.93%)

Closing price 03:59 PM Eastern

Extended Trading

$1.48 +0.02 (+1.37%)

As of 04:05 PM Eastern

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time